Cargando…
Continuous extracorporeal treatments in a dialysis patient with COVID-19
The coronavirus disease 2019 (COVID-19) pandemic is now a major global health threat. More than half a year have passed since the first discovery of severe acute respiratory syndrome coronavirus-2 (SARS-CoV2), no effective treatment has been established especially in intensive care unit. Inflammator...
Autores principales: | Nihei, Yoshihito, Nagasawa, Hajime, Fukao, Yusuke, Kihara, Masao, Ueda, Seiji, Gohda, Tomohito, Suzuki, Yusuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532984/ https://www.ncbi.nlm.nih.gov/pubmed/33011959 http://dx.doi.org/10.1007/s13730-020-00538-x |
Ejemplares similares
-
COVID-19-induced acute renal tubular injury associated with elevation of serum inflammatory cytokine
por: Fukao, Yusuke, et al.
Publicado: (2021) -
Association of advanced glycation end products with sarcopenia and frailty in chronic kidney disease
por: Yabuuchi, Junko, et al.
Publicado: (2020) -
IgA Nephropathy with Gross Hematuria Following COVID-19 mRNA Vaccination
por: Nihei, Yoshihito, et al.
Publicado: (2022) -
Gross hematuria after SARS-CoV-2 vaccination: questionnaire survey in Japan
por: Matsuzaki, Keiichi, et al.
Publicado: (2021) -
Correction to: Gross hematuria after SARS-CoV-2 vaccination: questionnaire survey in Japan
por: Matsuzaki, Keiichi, et al.
Publicado: (2021)